Wockhardt Financial Statements

Wockhardt (WOCKPHARMA) reported revenue of ₹30.74B in FY2025 with net income of -₹570.00M. Total assets stood at ₹81.35B and free cash flow was -₹1.16B.

Wockhardt Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		27.08B	32.30B	26.51B	28.81B	30.74B
Cost of Rev. Cost of Revenue		-11.38B	-12.67B	-11.11B	-11.65B	-12.38B
Gross Profit		15.70B	19.63B	15.40B	17.16B	18.36B
SGA Sales, General & Admin		-16.33B	-16.65B	-14.39B	-15.94B	-14.87B
Op. Income Operating Income		-3.09B	510.00M	-1.50B	-1.01B	1.32B
PBT Profit Before Tax		-4.26B	-4.11B	-6.24B	-4.20B	-160.00M
Net Income		6.86B	-2.79B	-6.21B	-4.72B	-570.00M
Dil. Shares Diluted Shares		111.23M	120.56M	144.06M	144.47M	155.63M
Diluted EPS		61.68	-20.24	-38.79	-32.05	-3.02

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Wockhardt's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Wockhardt Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		24.24B	25.89B	22.08B	20.73B	25.69B
Non-curr. assets Total non-current assets		53.48B	56.54B	54.75B	55.76B	55.66B
Total assets		77.73B	82.43B	76.83B	76.49B	81.35B
Curr. liabilities Total current liabilities		31.18B	32.07B	34.35B	27.91B	20.42B
Non-curr. liab. Total non-current liabilities		8.94B	8.34B	5.86B	11.96B	14.36B
Total liabilities		40.12B	40.41B	40.21B	39.87B	34.78B
Total equity		37.60B	42.02B	36.62B	36.62B	46.57B
Total liab. & eq. Total liabilities & equity		77.73B	82.43B	76.83B	76.49B	81.35B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Wockhardt's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Wockhardt Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		9.16B	-4.11B	-6.24B	-4.20B	-160.00M
Operating CF Cash flow Operating Activities		-2.87B	4.13B	1.53B	2.19B	-220.00M
Capex Investments in PPE		-805.40M	-2.12B	-2.09B	-590.00M	-940.00M
Investing CF Cash flow Investing Activities		14.70B	-2.01B	-1.25B	-1.37B	-7.83B
Dividend Paid		-5.30M	-20.00M	0	0	0
Financing CF Cash flow Financing Activities		-11.71B	-710.00M	-3.15B	3.34B	4.09B
Cash (start) Cash at beginning of period		2.19B	2.32B	3.70B	900.00M	5.05B
Cash (end) Cash at end of period		2.32B	3.70B	900.00M	5.05B	1.12B
FCF Free Cash Flow		-3.68B	2.01B	-560.00M	1.60B	-1.16B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Wockhardt's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025